[Chinese consensus on the use of antiarrhythmic drugs for rhythm control in atrial fibrillation].
Zhonghua Nei Ke Za Zhi
; 62(4): 343-355, 2023 Apr 01.
Article
em Zh
| MEDLINE
| ID: mdl-37032128
ABSTRACT
Rhythm control is crucial part of comprehensive management of atrial fibrillation (AF). Rhythm control can reduce the burden of AF effectively, reduce symptoms, and improve the prognosis in early AF. Antiarrhythmic drugs (AADs) are the first-line treatment for rhythm-control strategies. This consensus focuses on the principle of rhythm control in AF, the characteristics of AADs, and the medication recommendations for patients in different populations suffering from AF. Hence, this consensus aims to support clinical decision-making for AF therapy.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fibrilação Atrial
/
Antiarrítmicos
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Humans
País/Região como assunto:
Asia
Idioma:
Zh
Revista:
Zhonghua Nei Ke Za Zhi
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
China